Association Between Maternal Pre-Pregnancy Body Mass Index and Growth Delay in Korean Children Aged 18-36 Months: A Population-Based Study.

IF 3 3区 医学 Q2 HEALTH CARE SCIENCES & SERVICES
Eun-Jung Oh, Tae-Eun Kim, Sang-Hyun Park, Hye Won Park, Hyuk Jung Kweon, Jaekyung Choi, Jinyoung Shin
{"title":"Association Between Maternal Pre-Pregnancy Body Mass Index and Growth Delay in Korean Children Aged 18-36 Months: A Population-Based Study.","authors":"Eun-Jung Oh, Tae-Eun Kim, Sang-Hyun Park, Hye Won Park, Hyuk Jung Kweon, Jaekyung Choi, Jinyoung Shin","doi":"10.3390/jpm15060261","DOIUrl":null,"url":null,"abstract":"<p><p><b>Background:</b> Maternal pre-pregnancy body mass index (BMI) has been linked to childhood growth. However, its effects on growth delay at different early life stages are not well understood. This study aimed to evaluate the relationship between maternal pre-pregnancy BMI and growth delay in Korean children, using data from the National Health Screening Program for Infants and Children. <b>Methods</b>: Data from 258,367 children born between 2014 and 2021 who underwent health screenings at both 18-24 and 30-36 months of age were analyzed. Maternal BMI within three years before childbirth was classified into five categories: <18.5, 18.5-22.9 (reference), 23-24.9, 25-29.9, and ≥30 kg/m<sup>2</sup>. Growth delay was defined as measurements below the 10th percentile for height, weight, and head circumference. Adjusted relative risks (RRs) were estimated using regression models controlling for maternal age, comorbidities, and perinatal factors. <b>Results</b>: An increased risk of height growth delay was observed with higher maternal BMI, and this association persisted at both 18-24 and 30-36 months. In contrast, maternal underweight was not significantly associated with a height delay. Low maternal BMI was associated with underweight status in children. Head circumference growth delay was linked to both high and low maternal BMI; children of mothers outside the normal BMI range had an increased risk. <b>Conclusions</b>: Maternal pre-pregnancy obesity and underweight were associated with growth delays in height, weight, and head circumference in children up to 36 months of age. These findings underscore the importance of individualized weight management before pregnancy.</p>","PeriodicalId":16722,"journal":{"name":"Journal of Personalized Medicine","volume":"15 6","pages":""},"PeriodicalIF":3.0000,"publicationDate":"2025-06-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12194578/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Personalized Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3390/jpm15060261","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"HEALTH CARE SCIENCES & SERVICES","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Maternal pre-pregnancy body mass index (BMI) has been linked to childhood growth. However, its effects on growth delay at different early life stages are not well understood. This study aimed to evaluate the relationship between maternal pre-pregnancy BMI and growth delay in Korean children, using data from the National Health Screening Program for Infants and Children. Methods: Data from 258,367 children born between 2014 and 2021 who underwent health screenings at both 18-24 and 30-36 months of age were analyzed. Maternal BMI within three years before childbirth was classified into five categories: <18.5, 18.5-22.9 (reference), 23-24.9, 25-29.9, and ≥30 kg/m2. Growth delay was defined as measurements below the 10th percentile for height, weight, and head circumference. Adjusted relative risks (RRs) were estimated using regression models controlling for maternal age, comorbidities, and perinatal factors. Results: An increased risk of height growth delay was observed with higher maternal BMI, and this association persisted at both 18-24 and 30-36 months. In contrast, maternal underweight was not significantly associated with a height delay. Low maternal BMI was associated with underweight status in children. Head circumference growth delay was linked to both high and low maternal BMI; children of mothers outside the normal BMI range had an increased risk. Conclusions: Maternal pre-pregnancy obesity and underweight were associated with growth delays in height, weight, and head circumference in children up to 36 months of age. These findings underscore the importance of individualized weight management before pregnancy.

韩国18-36月龄儿童孕妇孕前体重指数与生长迟缓的关系:一项基于人群的研究
背景:孕妇孕前体重指数(BMI)与儿童发育有关。然而,它对生命早期不同阶段生长延迟的影响尚不清楚。本研究旨在评估母亲孕前BMI与韩国儿童生长迟缓之间的关系,使用的数据来自国家婴儿和儿童健康筛查计划。方法:分析了2014年至2021年间出生的258,367名在18-24个月和30-36个月大时接受健康筛查的儿童的数据。产妇产前3年内BMI分为5类:生长迟缓定义为身高、体重和头围低于第10个百分位数。校正后的相对危险度(rr)使用控制产妇年龄、合并症和围产期因素的回归模型进行估计。结果:母亲BMI越高,身高生长迟缓的风险越高,这种关联在18-24个月和30-36个月时持续存在。相比之下,母亲体重不足与身高延迟没有显著关联。母亲体重指数低与儿童体重过轻有关。头围生长延迟与母亲BMI的高低有关;母亲体重指数超出正常范围的孩子的风险会增加。结论:母亲孕前肥胖和体重不足与36个月以下儿童的身高、体重和头围发育迟缓有关。这些发现强调了孕前个体化体重管理的重要性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of Personalized Medicine
Journal of Personalized Medicine Medicine-Medicine (miscellaneous)
CiteScore
4.10
自引率
0.00%
发文量
1878
审稿时长
11 weeks
期刊介绍: Journal of Personalized Medicine (JPM; ISSN 2075-4426) is an international, open access journal aimed at bringing all aspects of personalized medicine to one platform. JPM publishes cutting edge, innovative preclinical and translational scientific research and technologies related to personalized medicine (e.g., pharmacogenomics/proteomics, systems biology). JPM recognizes that personalized medicine—the assessment of genetic, environmental and host factors that cause variability of individuals—is a challenging, transdisciplinary topic that requires discussions from a range of experts. For a comprehensive perspective of personalized medicine, JPM aims to integrate expertise from the molecular and translational sciences, therapeutics and diagnostics, as well as discussions of regulatory, social, ethical and policy aspects. We provide a forum to bring together academic and clinical researchers, biotechnology, diagnostic and pharmaceutical companies, health professionals, regulatory and ethical experts, and government and regulatory authorities.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信